CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
TOTAL REVENUES	$ 3,269,000	$ 0	$ 16,707,000	$ 308,000
EXPENSES
Cost of goods sold	371,000	0	858,000	0
Research and development	6,623,000	12,452,000	35,695,000	35,856,000
Selling, general and administrative	19,766,000	10,747,000	71,640,000	22,894,000
Goodwill and in-process research & development impairments	0	0	54,345,000	0
Contingent Stock Right Remeasurement	0	0	84,726,000	0
TOTAL EXPENSES	26,760,000	23,199,000	247,264,000	58,750,000
OPERATING LOSS	23,491,000	23,199,000	230,557,000	58,442,000
FINANCE INCOME	(4,000)	(381,000)	(1,218,000)	(1,385,000)
FINANCE EXPENSES	1,226,000	343,000	3,306,000	477,000
LOSS BEFORE INCOME TAX	24,713,000	23,161,000	232,645,000	57,534,000
INCOME TAX	1,000	0	(258,000)	(176,000)
NET LOSS FOR THE PERIOD	$ 24,714,000	$ 23,161,000	$ 232,387,000	$ 57,358,000
LOSS PER SHARE BASIC AND DILUTED (in dollars per share)	$ 0.15	$ 0.23	$ 1.99	$ 0.59
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE (in shares)	167,737	100,805	116,530	97,989
Product sales
TOTAL REVENUES	$ 2,863,000	$ 0	$ 6,096,000	$ 0
License revenues
TOTAL REVENUES	0	0	10,000,000	0
Royalty revenues
TOTAL REVENUES	$ 406,000	$ 0	$ 611,000	$ 308,000